Back close

In vitro studies on pharmacological potential of mycoendophyte of Simarouba glauca

Start Date: Friday, Jan 01,2016

End Date: Tuesday, May 31,2016

In vitro studies on pharmacological potential of mycoendophyte of Simarouba glauca

The exploration of endophytes is still an emerging field. Almost all plants seem to deliver endophytes with promising contents and activities. Simarouba glauca has a long history in herbal medicine as antiparasitic, antidysentric, antipyretic and anti cancerous agent in many countries. Recently the plant extract has received much attention in India as an anti cancer and anti arthritic medicine.  In the present study endophytic fungi from Simarouba glauca were isolated and evaluated for their pharmacological properties. SG-S, an endophytic fungus isolated in our study was found to exhibit anti bacterial, anti oxidant and anti hyper glycaemic potential. Qualitative phyto chemical analysis of the crude extract of SG-S showed presence of flavanoids, triterpenes, alkaloids and carbohydrates, many of them being  reported to have bio active properties. Further research is needed to characterize the isolate and purify the compounds. Thus the medicinal plant S.glauca could be a great source material for isolation of endophytes with bioactive metabolites.

Related Projects

Study of Waste Management Practices and Impact on Rural Ecosystems
Study of Waste Management Practices and Impact on Rural Ecosystems
Development of Entropy alloys and detemination of their Mechanical Properties including Hardness and wear rate
Development of Entropy alloys and detemination of their Mechanical Properties including Hardness and wear rate
Development of an Epidemiological Model to Modify Cardiovascular Risk Profile in Children
Development of an Epidemiological Model to Modify Cardiovascular Risk Profile in Children
School Programs, 2nd Foundation Program
School Programs, 2nd Foundation Program
Cancers, Treated with VEGF and HER 2/neu Receptor Tyrosine Kinase Inhibitors
Cancers, Treated with VEGF and HER 2/neu Receptor Tyrosine Kinase Inhibitors
Admissions Apply Now